Galmed Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on the clinical development of drugs for liver, metabolic, and inflammatory diseases. Our leading drug candidate, Aramchol™, is being studied in a Phase 3 trial for the treatment of NASH and fibrosis.
Galmed Pharmaceuticals has raised $7.0M across 1 funding round on record, the most recent an undisclosed round of $7.0M announced in Jul 2023.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Galmed Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Galmed Pharmaceuticals Funding Rounds
Galmed Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Galmed Pharmaceuticals Funding Compared to Other Health Care Startups
Galmed Pharmaceuticals' latest round of $7.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Galmed Pharmaceuticals in Health Care and Tel Aviv
Companies Similar to Galmed Pharmaceuticals
QuantHealth is an organization that produces software using artificial intelligence technology for drug…
Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory…
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and…
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma…
Vortex Imaging develops medical imaging devices.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and…
VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for…
Fize Medical is a health care company based in Israel.
Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation,…
TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide…
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox…
Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They…
Galmed Pharmaceuticals Funding FAQs
What does Galmed Pharmaceuticals do?
Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on the clinical development of drugs for liver, metabolic, and inflammatory diseases. Our leading drug candidate, Aramchol™, is being studied in a Phase 3 trial for the treatment of NASH and fibrosis.
How much funding has Galmed Pharmaceuticals raised?
Galmed Pharmaceuticals has raised $7.0M across 1 round on record. The most recent is an undisclosed round of $7.0M announced in Jul 2023.
When did Galmed Pharmaceuticals last raise funding?
Galmed Pharmaceuticals' most recent funding round on record is an undisclosed round of $7.0M, announced in Jul 2023.
Who founded Galmed Pharmaceuticals?
FundedIQ lists Tuvia Gilat (Founder) at Galmed Pharmaceuticals.
Where is Galmed Pharmaceuticals headquartered?
Galmed Pharmaceuticals is based in Tel Aviv, Israel.
How many employees does Galmed Pharmaceuticals have?
Galmed Pharmaceuticals is in the 11-50 employee band.
How does Galmed Pharmaceuticals' funding compare to other Health Care startups?
Galmed Pharmaceuticals' latest round of $7.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Galmed Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Galmed Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.